Basic science: (SEPTEMBER 2007)

Abstract

1. Abba MC, Sun H, Hawkins KA, Drake JA, Hu Y, Nunez MI, Gaddis S, Shi T, Horvath S, Sahin A and Aldaz CM. Breast cancer molecular signatures as determined by SAGE: correlation with lymph node status. Mol Cancer Res 2007; 5: 881–890. 2. Alarmo EL, Korhonen T, Kuukasjaervi T, Huhtala H, Holli K and Kallioniemi A. Bone morphogenetic protein 7 expression associates with bone metastasis in breast carcinomas. Ann Oncol 2007; 10.1093/annonc/mdm453. 3. Andarawewa KL, Erickson AC, Chou WS, Costes SV, Gascard P, Mott JD, Bissell MJ and Barcellos-Hoff MH. Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor b-induced epithelial to mesenchymal transition. Cancer Res 2007; 67: 8662–8670. 4. Balasubramanian SP, Cox A, Cross SS, Higham SE, Brown NJ and Reed MW. Influence of VEGF-A gene variation and protein levels in breast cancer susceptibility and severity. Int J Cancer 2007; 121: 1009–1016. 5. Bromberg KD, Kluger HM, Delaunay A, Abbas S, DiVito KA, Krajewski S and Ronai Z. Increased expression of the E3 ubiquitin ligase RNF5 is associated with decreased survival in breast cancer. Cancer Res 2007; 67: 8172–8179. 6. Buijs JT, Henriquez NV, Van Overveld PGM, Van der Horst G, Que I, Schwaninger R, Rentsch C, Ten Dijke P, Cleton-Jansen AM, Driouch K, Lidereau R, Bachelier R, Vukicevic S, Clezardin P, Papapoulos SE, Cecchini MG, Lowik C and Van der Pluijm G. Bone morphogenetic protein 7 in the development and treatment of bone Metastases from breast cancer. Cancer Res 2007; 67: 8742–8751. 7. Cao Y, Luo J and Karin M. IkB kinase a kinase activity is required for self-renewal of ErbB2/ Her2-transformed mammary tumor-initiating cells. Proc Natl Acad Sci USA 2007; 104: 15852–15857. 8. Chen D, Reierstad S, Lin Z, Lu M, Brooks C, Li N, Innes J and Bulun SE. Prostaglandin E-2 induces breast cancer-related aromatase promoters via activation of p38 and c-jun NH2Terminal kinase in adipose fibroblasts. Cancer Res 2007; 67: 8914–8922. 9. Christov K, Grubbs CJ, Shilkaitis A, Juliana MM and Lubet RA. Short-term modulation of cell proliferation and apoptosis and preventive/ Therapeutic efficacy of various agents in a mammary cancer model. Clin Cancer Res 2007; 13: 5488–5496. 10. Dairkee SH, Nicolau M, Sayeed A, Champion S, Ji Y, Moore DH, Yong B, Meng Z and Jeffrey SS. Oxidative stress pathways highlighted in tumor cell immortalization: association with breast cancer outcome. Oncogene 2007; 26: 6269–6279. 11. Deeb KK, Michalowska AM, Yoon CY, Krummey SM, Hoenerhoff MJ, Kavanaugh C, Li MC, Demayo FJ, Linnoila I, Deng CX, Lee E, Medina D, Shih JH and Green JE. Identification of an integrated SV40 T/t-antigen cancer signature in aggressive human breast, prostate, and lung carcinomas with poor prognosis. Cancer Res 2007; 67: 8065–8080. 12. Dupont VN, Gentien D, Oberkampf M, De Rycke Y and Blin N. A gene expression signature associated with metastatic cells in effusions of breast carcinoma patients. Int J Cancer 2007; 121: 1036–1046. 13. Fernando R, Foster JS, Bible A, Strom A, Pestell RG, Rao M, Saxton A, Baek SJ, Yamaguchi K, Donnell R, Cekanova M and Wimalasena J. Breast cancer cell proliferation is inhibited by BAD: Regulation of CYCLIN D1. J Biol Chem 2007; 282: 28864–28873. 14. Gonzalez ME, Peterson EA, Privette LM, Loffreda-Wren JL, Kalikin LM and Petty EM. High SEPT9_v1 expression in human breast cancer cells is associated with oncogenic phenotypes. Cancer Res 2007; 67: 8554–8564. 15. Green KA and Carroll JS. Opinion: Oestrogenreceptor-mediated transcription and the influence of co-factors and chromatin state. Nat Rev Cancer 2007; 7: 713–722. BCO/634/2007/JW